Procter & Gamble (PG) reported $22.21 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 1.5%. EPS of $1.88 for the same period compares to $1.88 a year ago.
The reported revenue represents a surprise of -0.36% over the Zacks Consensus Estimate of $22.29 billion. With the consensus EPS estimate being $1.87, the EPS surprise was +0.33%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how P&G performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Organic Sales Growth (YoY change) - Beauty: 4% versus 2.2% estimated by five analysts on average.
- Organic Sales Growth (YoY change) - Baby, Feminine & Family Care: -4% versus -2.2% estimated by five analysts on average.
- Organic Sales Growth (YoY change) - Health Care: 3% versus the five-analyst average estimate of 1%.
- Net Sales- Beauty: $4.04 billion versus the six-analyst average estimate of $3.99 billion. The reported number represents a year-over-year change of +5%.
- Net Sales- Grooming: $1.79 billion versus $1.8 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +2.4% change.
- Net Sales- Corporate: $160 million versus $166.23 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +0.6% change.
- Net Sales- Fabric & Home Care: $7.69 billion versus $7.67 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +1.5% change.
- Net Sales- Baby, Feminine & Family Care: $5.12 billion versus $5.28 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a -3.3% change.
- Net Sales- Health Care: $3.41 billion compared to the $3.31 billion average estimate based on six analysts. The reported number represents a change of +4.8% year over year.
- Earnings before income taxes- Beauty: $992 million versus the three-analyst average estimate of $1.07 billion.
- Earnings before income taxes- Grooming: $531 million versus the three-analyst average estimate of $577.96 million.
- Earnings before income taxes- Health Care: $1.01 billion versus $995.8 million estimated by three analysts on average.
View all Key Company Metrics for P&G here>>>
Shares of P&G have returned +1.1% over the past month versus the Zacks S&P 500 composite's +0.7% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Procter & Gamble Company (The) (PG): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
